What Is DUTCH Test

The DUTCH test (Dried Urine Test for Comprehensive Hormones) is a diagnostic panel that collects small urine samples on filter paper at multiple points throughout a day, then analyzes them for reproductive hormones, adrenal hormones, and the downstream metabolites produced as the body processes these compounds. Developed by Precision Analytical, it provides a map of hormone production and clearance that goes beyond what a single blood draw can show. The test is used primarily in functional and integrative medicine to inform decisions about hormone balance, stress physiology, and detoxification capacity.

Hormones do not act in isolation, and measuring only their circulating levels tells an incomplete story. How the body metabolizes estrogen, for example, matters as much as how much estrogen it produces: certain estrogen metabolites are associated with higher tissue proliferation risk, while others are considered more benign. Similarly, total cortisol production over a day reveals something fundamentally different from a single morning cortisol value. The DUTCH test addresses these layers by quantifying metabolites alongside parent hormones.

For anyone interested in longevity, this granularity has practical implications. Hormonal decline and shifting metabolism patterns are central features of aging in both sexes. Understanding whether fatigue stems from low cortisol production versus rapid cortisol clearance, or whether estrogen is being preferentially shunted down a particular metabolic pathway, allows for more targeted interventions. The test also includes markers related to methylation and oxidative stress, connecting hormonal health to broader systemic function.

The test relies on dried urine collected at four to five time points over a 24-hour period, typically starting in the evening and ending the following evening. Each sample is collected by saturating a small filter paper strip with urine, then allowing it to air dry. The dried samples are stable at room temperature and shipped to the lab by mail.

Once received, the lab uses liquid chromatography and mass spectrometry to identify and quantify individual hormone metabolites. For estrogen, this includes the three parent estrogens (estrone, estradiol, estriol) and their phase I metabolites (2-OH, 4-OH, and 16-OH pathways), along with methylation markers that reflect phase II detoxification activity. For androgens, the panel measures testosterone, DHEA, and their metabolites. The cortisol section captures free cortisol at each collection point (mapping the diurnal curve), total cortisol metabolites (reflecting overall adrenal output), and cortisone values that reveal the activity of the 11-beta-HSD enzyme system, which converts cortisol to its inactive form.

Some versions of the test (DUTCH Complete and DUTCH Plus) also measure melatonin's primary metabolite (6-OH melatonin sulfate) and organic acids related to B12, B6, glutathione status, and dopamine or norepinephrine turnover. The DUTCH Plus variant adds salivary cortisol awakening response (CAR) measurements to the dried urine data, providing finer resolution of the early morning cortisol spike that is often disrupted in HPA axis dysfunction.

The DUTCH test measures a broad panel of steroid hormones and their metabolites through dried urine samples. On the estrogen side, it quantifies estrone (E1), estradiol (E2), estriol (E3), and the phase I hydroxylated metabolites (2-hydroxyestrone, 4-hydroxyestrone, 16-hydroxyestrone), along with the methylated phase II metabolites (2-methoxyestrone, 2-methoxyestradiol) that indicate COMT-dependent detoxification. Androgen markers include testosterone, 5-alpha-DHT, DHEA-S, androsterone, and etiocholanolone.

The adrenal section captures free cortisol and free cortisone at each collection point, producing a diurnal rhythm curve, plus total cortisol metabolites (tetrahydrocortisol, tetrahydrocortisone, and others) that reflect 24-hour adrenal output. This distinction between free cortisol and metabolized cortisol is one of the test's distinguishing features, as it separates production volume from what appears in circulation at any given moment.

Depending on the version ordered, additional markers include 6-hydroxymelatonin sulfate (a proxy for melatonin production), 8-hydroxy-2-deoxyguanosine (8-OHdG, an oxidative stress marker), and several organic acids: methylmalonic acid (B12 status), xanthurenate (B6 status), pyroglutamate (glutathione demand), and homovanillate and vanilmandelate (dopamine and norepinephrine turnover). The DUTCH Plus version adds a saliva-based cortisol awakening response to capture the first 30 to 60 minutes after waking.

Preparation for the DUTCH test centers on collecting samples under conditions that represent your normal physiology. Avoid alcohol for 24 hours before and during the collection period, as alcohol significantly alters cortisol and hormone metabolism. Excessive water intake should be avoided in the two hours before each sample, since overly dilute urine can reduce the concentration of analytes below detectable thresholds.

If you are taking any form of hormone therapy (oral, topical, pellet, or injectable), discuss timing with your ordering practitioner. Some providers prefer testing at trough levels to assess baseline function, while others want to see how the body is metabolizing supplemented hormones. Biotin supplements above 5 mg per day should be discontinued at least 72 hours before collection as a precaution, although mass spectrometry is less sensitive to biotin interference than immunoassay-based tests. For menstruating women, the test is typically collected on days 19 to 22 of the cycle (the mid-luteal phase) to capture peak progesterone and assess the full estrogen and progesterone metabolite picture. Postmenopausal women and men can test on any day.

DUTCH test results are presented in a multi-page report that groups markers into sections: estrogen production and metabolism, androgen production, adrenal hormones (cortisol, cortisone, DHEA), melatonin, and organic acids. Each marker is plotted against a reference range derived from the lab's population data, and color coding indicates whether a value falls within, above, or below typical ranges.

The estrogen section is where metabolite ratios carry clinical weight. A high proportion of 4-OH metabolites relative to 2-OH metabolites has been associated in biochemical research with greater oxidative potential, while robust methylation (shown by adequate 2-methoxy metabolites) suggests the body is effectively neutralizing reactive estrogen intermediates. The cortisol section requires careful reading: someone with low free cortisol but high metabolized cortisol is not necessarily producing less cortisol; they may be clearing it rapidly, which calls for a different approach than true adrenal insufficiency.

The organic acid markers provide context beyond hormones. Elevated methylmalonic acid may point to functional B12 insufficiency, and high pyroglutamate can signal increased glutathione demand. These markers do not diagnose conditions on their own but flag areas for further investigation. The overall picture is most useful when a practitioner integrates the DUTCH data with symptoms, blood work (including SHBG, LH, FSH, thyroid markers), and clinical history.

For most people, a DUTCH test serves as a detailed baseline that does not need frequent repetition. An initial test establishes hormone production patterns, metabolite ratios, and cortisol rhythm. If interventions are made based on the results (such as targeted supplementation to support methylation, changes to hormone therapy dosing, or lifestyle modifications for adrenal support), a follow-up test three to six months later can assess whether those changes have shifted the relevant markers.

Ongoing annual testing may be useful for individuals on hormone replacement therapy, those managing conditions like estrogen dominance or adrenal dysfunction, or anyone tracking age-related hormonal shifts through perimenopause, menopause, or andropause. Outside of these contexts, repeating the test more than once or twice a year is unlikely to yield new actionable information. The cost of the test makes strategic timing important: test when the results will directly inform a decision rather than for routine surveillance.

The analytical chemistry behind the DUTCH test (liquid chromatography tandem mass spectrometry for urinary steroid profiling) is well established and widely used in clinical and research laboratories. Urinary hormone metabolite profiling has decades of precedent in endocrinology, and the 24-hour urine collection for cortisol metabolites has long been a standard research tool. What the DUTCH format adds is convenience (dried samples rather than a jug) and a consumer-friendly report layout. Precision Analytical has published validation data comparing its dried urine method to established 24-hour urine and salivary cortisol methods, showing strong correlations for most analytes.

That said, the clinical interpretation framework used to guide treatment decisions based on DUTCH results is largely derived from functional medicine consensus rather than large randomized trials. For example, while the association between the 4-OH estrogen pathway and oxidative DNA damage is supported by biochemical and epidemiological research, the clinical significance of shifting metabolite ratios through supplementation has not been established in prospective outcome trials. The cortisol metabolite data is analytically sound, but treatment protocols based on these patterns rely on clinical experience and smaller studies rather than definitive evidence. The DUTCH test is best understood as a high-resolution diagnostic tool whose interpretation depends heavily on practitioner expertise.

The DUTCH test carries no physical risk, as it involves only urine collection. The primary considerations are financial (it is not covered by most insurance and costs several hundred dollars) and interpretive. Results can be complex, and acting on them without a knowledgeable practitioner risks unnecessary supplementation or inappropriate hormone use. Certain conditions, including kidney disease, can alter urinary hormone excretion and reduce the test's reliability. Results should always be interpreted alongside symptoms, medical history, and complementary lab work rather than treated as standalone directives.